Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma.

Matsushita, Tomomi; Sekizawa, Akihiko; Jacobs, Lisa K

Matsushita, Tomomi; Sekizawa, Akihiko; Jacobs, Lisa K.

Affiliation

Matsushita T; Johns Hopkins Bloomberg School of Public Health (Dr. Matsushita), Baltimore, Maryland; Department of Obstetrics and Gynecology (Drs. Matsushita and Sekizawa), Showa University School of Medicine, Japan. Electronic address: Tomomi.Matsushita@jhu.edu.
Sekizawa A; Department of Obstetrics and Gynecology (Drs. Matsushita and Sekizawa), Showa University School of Medicine, Japan.
Jacobs LK; Department of Surgery, Tokyo, Japan (Dr. Jacobs), Johns Hopkins University School of Medicine, Baltimore, Maryland.

J Minim Invasive Gynecol ; 27(1): 178-185.e1, 2020 01.

Article in En | MEDLINE | ID: mdl-30936031

Subject(s)
Key words

Abdominal myomectomy; FDA safety communication; Laparoscopic myomectomy; Racial disparity; Uterine morcellation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Laparoscopy / Healthcare Disparities / Uterine Myomectomy / Morcellation / Laparotomy / Leiomyoma Type of study: Observational_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Adolescent / Adult / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: J Minim Invasive Gynecol Journal subject: GINECOLOGIA Year: 2020 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google